AksharChem (India) Limited
NSE:AKSHARCHEM.NS
341.1 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,020.47 | 3,346.786 | 3,682.191 | 2,464.829 | 2,556.985 | 3,193.409 | 2,642.587 | 2,596.521 | 1,877.061 | 1,998.158 | 1,448.733 | 958.303 | 518.94 | 845.565 | 815.762 | 536.945 |
| Cost of Revenue
| 2,615.677 | 2,580.423 | 2,412.149 | 1,482.229 | 1,546.415 | 2,100.181 | 1,642.803 | 1,619.761 | 1,415.678 | 1,587.038 | 1,030.111 | 851.169 | 497.882 | 773.527 | 740.323 | 538.137 |
| Gross Profit
| 404.793 | 766.363 | 1,270.042 | 982.6 | 1,010.57 | 1,093.228 | 999.784 | 976.759 | 461.383 | 411.121 | 418.622 | 107.134 | 21.058 | 72.038 | 75.439 | -1.192 |
| Gross Profit Ratio
| 0.134 | 0.229 | 0.345 | 0.399 | 0.395 | 0.342 | 0.378 | 0.376 | 0.246 | 0.206 | 0.289 | 0.112 | 0.041 | 0.085 | 0.092 | -0.002 |
| Reseach & Development Expenses
| 0 | 1.729 | 2.025 | 1.506 | 1.364 | 1.592 | 1 | 1.004 | 1.105 | 1.08 | 0.561 | 0.319 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 56.049 | 58.184 | 39.892 | 32.508 | 28.725 | 22.792 | 16.464 | 10.095 | 41.458 | 29.261 | 4.134 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 57.006 | 102.066 | 67.277 | 74.233 | 91.216 | 63.902 | 55.169 | 42.822 | 39.951 | 22.887 | 21.882 | 16.401 | 0 | 0 | 0 |
| SG&A
| 527.632 | 113.055 | 160.25 | 107.169 | 106.741 | 119.941 | 86.694 | 71.633 | 52.917 | 81.409 | 52.148 | 21.882 | 16.401 | 0 | 0 | 0 |
| Other Expenses
| 4.487 | 1.517 | 0.722 | 0.47 | 0.42 | 0.392 | 0.035 | 156.885 | 128.438 | 96.644 | 51.29 | 36.107 | 31.898 | 53.241 | 46.267 | 42.47 |
| Operating Expenses
| 527.632 | 740.72 | 1,118.02 | 813.954 | 860.612 | 838.916 | 629.029 | 228.518 | 181.355 | 178.053 | 103.437 | 57.989 | 48.3 | 53.241 | 46.267 | 42.47 |
| Operating Income
| -122.839 | 25.643 | 194.989 | 168.646 | 195.863 | 289.741 | 370.755 | 775.867 | 259.274 | 235.097 | 289.58 | 33.872 | -42.246 | 62.121 | 16.481 | -53.053 |
| Operating Income Ratio
| -0.041 | 0.008 | 0.053 | 0.068 | 0.077 | 0.091 | 0.14 | 0.299 | 0.138 | 0.118 | 0.2 | 0.035 | -0.081 | 0.073 | 0.02 | -0.099 |
| Total Other Income Expenses Net
| -32.78 | -30.633 | -15.521 | 4.36 | -4.767 | 44.328 | 55.718 | 27.626 | -20.754 | 2.03 | -25.605 | -15.272 | -15.005 | 43.323 | -12.691 | -9.391 |
| Income Before Tax
| -155.619 | -4.99 | 179.468 | 173.006 | 191.096 | 334.069 | 426.473 | 775.867 | 259.274 | 235.097 | 289.58 | 33.872 | -42.246 | 62.121 | 16.481 | -53.053 |
| Income Before Tax Ratio
| -0.052 | -0.001 | 0.049 | 0.07 | 0.075 | 0.105 | 0.161 | 0.299 | 0.138 | 0.118 | 0.2 | 0.035 | -0.081 | 0.073 | 0.02 | -0.099 |
| Income Tax Expense
| 31.154 | 4.431 | 20.32 | 47.997 | 33.869 | 108.174 | 120.304 | 256.679 | 92.913 | 75.095 | 89.151 | -4.061 | -3.377 | -1.608 | 1.279 | -2.09 |
| Net Income
| -186.773 | -9.421 | 159.148 | 125.009 | 157.227 | 225.895 | 306.169 | 519.188 | 166.362 | 160.002 | 200.429 | 37.933 | -38.869 | 63.729 | 15.131 | -51.035 |
| Net Income Ratio
| -0.062 | -0.003 | 0.043 | 0.051 | 0.061 | 0.071 | 0.116 | 0.2 | 0.089 | 0.08 | 0.138 | 0.04 | -0.075 | 0.075 | 0.019 | -0.095 |
| EPS
| -23.25 | -1.17 | 19.5 | 15.24 | 19.17 | 27.54 | 37.33 | 72.36 | 22.75 | 21.88 | 43.69 | 7.66 | -7.85 | 18.73 | 4.45 | -15 |
| EPS Diluted
| -23.25 | -1.17 | 19.5 | 15.24 | 19.17 | 27.54 | 37.33 | 72.36 | 22.75 | 21.88 | 40.47 | 7.66 | -7.85 | 18.73 | 4.45 | -15 |
| EBITDA
| 14.993 | 155.644 | 312.824 | 242.053 | 262.733 | 353.203 | 435.146 | 788.786 | 314.663 | 270.114 | 342.994 | 61.003 | -18.061 | -28.59 | 33.547 | -36.038 |
| EBITDA Ratio
| 0.005 | 0.047 | 0.085 | 0.098 | 0.103 | 0.111 | 0.165 | 0.304 | 0.168 | 0.135 | 0.237 | 0.064 | -0.035 | -0.034 | 0.041 | -0.067 |